nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—BCHE—epilepsy syndrome	0.254	1	CbGaD
Cinchocaine—SCN10A—Lacosamide—epilepsy syndrome	0.0728	0.128	CbGbCtD
Cinchocaine—SCN10A—Lamotrigine—epilepsy syndrome	0.0728	0.128	CbGbCtD
Cinchocaine—SCN5A—Oxcarbazepine—epilepsy syndrome	0.0682	0.12	CbGbCtD
Cinchocaine—SCN10A—Rufinamide—epilepsy syndrome	0.0643	0.113	CbGbCtD
Cinchocaine—SCN5A—Fosphenytoin—epilepsy syndrome	0.0596	0.105	CbGbCtD
Cinchocaine—SCN5A—Lamotrigine—epilepsy syndrome	0.0498	0.0877	CbGbCtD
Cinchocaine—SCN5A—Rufinamide—epilepsy syndrome	0.0439	0.0775	CbGbCtD
Cinchocaine—SCN5A—Carbamazepine—epilepsy syndrome	0.0428	0.0755	CbGbCtD
Cinchocaine—SCN5A—Phenytoin—epilepsy syndrome	0.0384	0.0677	CbGbCtD
Cinchocaine—SCN5A—Zonisamide—epilepsy syndrome	0.0317	0.0558	CbGbCtD
Cinchocaine—SCN5A—Topiramate—epilepsy syndrome	0.0231	0.0407	CbGbCtD
Cinchocaine—CALM2—pons—epilepsy syndrome	0.00294	0.0663	CbGeAlD
Cinchocaine—CALM1—pons—epilepsy syndrome	0.00292	0.066	CbGeAlD
Cinchocaine—CALM1—autonomic nervous system—epilepsy syndrome	0.0027	0.0608	CbGeAlD
Cinchocaine—SCN10A—ganglion—epilepsy syndrome	0.00244	0.055	CbGeAlD
Cinchocaine—CALM2—ear—epilepsy syndrome	0.00242	0.0546	CbGeAlD
Cinchocaine—CALM1—ear—epilepsy syndrome	0.00241	0.0543	CbGeAlD
Cinchocaine—CALM2—ganglion—epilepsy syndrome	0.0015	0.0339	CbGeAlD
Cinchocaine—CALM1—ganglion—epilepsy syndrome	0.0015	0.0338	CbGeAlD
Cinchocaine—Lucanthone—APEX1—epilepsy syndrome	0.00127	0.209	CrCbGaD
Cinchocaine—CALM2—hindbrain—epilepsy syndrome	0.00114	0.0257	CbGeAlD
Cinchocaine—CALM1—hindbrain—epilepsy syndrome	0.00114	0.0256	CbGeAlD
Cinchocaine—SCN10A—forebrain—epilepsy syndrome	0.00102	0.0231	CbGeAlD
Cinchocaine—SCN10A—telencephalon—epilepsy syndrome	0.000941	0.0212	CbGeAlD
Cinchocaine—CALM3—telencephalon—epilepsy syndrome	0.000739	0.0167	CbGeAlD
Cinchocaine—SCN10A—spinal cord—epilepsy syndrome	0.000659	0.0149	CbGeAlD
Cinchocaine—CALM2—brainstem—epilepsy syndrome	0.000654	0.0148	CbGeAlD
Cinchocaine—CALM1—brainstem—epilepsy syndrome	0.000651	0.0147	CbGeAlD
Cinchocaine—CALM2—forebrain—epilepsy syndrome	0.000631	0.0142	CbGeAlD
Cinchocaine—CALM1—forebrain—epilepsy syndrome	0.000628	0.0142	CbGeAlD
Cinchocaine—SCN10A—head—epilepsy syndrome	0.000586	0.0132	CbGeAlD
Cinchocaine—CALM3—medulla oblongata—epilepsy syndrome	0.000581	0.0131	CbGeAlD
Cinchocaine—CALM2—telencephalon—epilepsy syndrome	0.00058	0.0131	CbGeAlD
Cinchocaine—CALM1—telencephalon—epilepsy syndrome	0.000578	0.013	CbGeAlD
Cinchocaine—SCN10A—nervous system—epilepsy syndrome	0.000555	0.0125	CbGeAlD
Cinchocaine—BCHE—brainstem—epilepsy syndrome	0.000545	0.0123	CbGeAlD
Cinchocaine—SCN10A—central nervous system—epilepsy syndrome	0.000535	0.0121	CbGeAlD
Cinchocaine—SCN5A—head—epilepsy syndrome	0.000532	0.012	CbGeAlD
Cinchocaine—CALM3—midbrain—epilepsy syndrome	0.000531	0.012	CbGeAlD
Cinchocaine—BCHE—forebrain—epilepsy syndrome	0.000526	0.0119	CbGeAlD
Cinchocaine—CALM3—spinal cord—epilepsy syndrome	0.000518	0.0117	CbGeAlD
Cinchocaine—SCN5A—nervous system—epilepsy syndrome	0.000505	0.0114	CbGeAlD
Cinchocaine—SCN5A—central nervous system—epilepsy syndrome	0.000486	0.011	CbGeAlD
Cinchocaine—BCHE—telencephalon—epilepsy syndrome	0.000484	0.0109	CbGeAlD
Cinchocaine—Proparacaine—SCN3A—epilepsy syndrome	0.000461	0.0756	CrCbGaD
Cinchocaine—CALM2—medulla oblongata—epilepsy syndrome	0.000456	0.0103	CbGeAlD
Cinchocaine—CALM1—medulla oblongata—epilepsy syndrome	0.000454	0.0102	CbGeAlD
Cinchocaine—Amiodarone—CACNA2D2—epilepsy syndrome	0.000436	0.0715	CrCbGaD
Cinchocaine—SCN10A—brain—epilepsy syndrome	0.000425	0.00958	CbGeAlD
Cinchocaine—Oxybuprocaine—SCN3A—epilepsy syndrome	0.000422	0.0692	CrCbGaD
Cinchocaine—CALM2—midbrain—epilepsy syndrome	0.000417	0.0094	CbGeAlD
Cinchocaine—CALM1—midbrain—epilepsy syndrome	0.000415	0.00936	CbGeAlD
Cinchocaine—CALM3—cerebellum—epilepsy syndrome	0.000411	0.00926	CbGeAlD
Cinchocaine—CALM2—spinal cord—epilepsy syndrome	0.000407	0.00917	CbGeAlD
Cinchocaine—CALM1—spinal cord—epilepsy syndrome	0.000405	0.00913	CbGeAlD
Cinchocaine—SCN5A—brain—epilepsy syndrome	0.000386	0.0087	CbGeAlD
Cinchocaine—BCHE—medulla oblongata—epilepsy syndrome	0.00038	0.00858	CbGeAlD
Cinchocaine—CALM2—head—epilepsy syndrome	0.000361	0.00815	CbGeAlD
Cinchocaine—CALM1—head—epilepsy syndrome	0.00036	0.00812	CbGeAlD
Cinchocaine—BCHE—midbrain—epilepsy syndrome	0.000347	0.00784	CbGeAlD
Cinchocaine—CALM2—nervous system—epilepsy syndrome	0.000343	0.00773	CbGeAlD
Cinchocaine—CALM1—nervous system—epilepsy syndrome	0.000341	0.00769	CbGeAlD
Cinchocaine—BCHE—spinal cord—epilepsy syndrome	0.000339	0.00765	CbGeAlD
Cinchocaine—CALM3—brain—epilepsy syndrome	0.000333	0.00752	CbGeAlD
Cinchocaine—CALM2—central nervous system—epilepsy syndrome	0.00033	0.00744	CbGeAlD
Cinchocaine—CALM1—central nervous system—epilepsy syndrome	0.000328	0.00741	CbGeAlD
Cinchocaine—Proparacaine—SCN1A—epilepsy syndrome	0.000324	0.0531	CrCbGaD
Cinchocaine—CALM2—cerebellum—epilepsy syndrome	0.000322	0.00727	CbGeAlD
Cinchocaine—CALM1—cerebellum—epilepsy syndrome	0.000321	0.00724	CbGeAlD
Cinchocaine—BCHE—head—epilepsy syndrome	0.000301	0.0068	CbGeAlD
Cinchocaine—Oxybuprocaine—SCN1A—epilepsy syndrome	0.000296	0.0486	CrCbGaD
Cinchocaine—BCHE—nervous system—epilepsy syndrome	0.000286	0.00645	CbGeAlD
Cinchocaine—Proparacaine—SCN2A—epilepsy syndrome	0.000285	0.0468	CrCbGaD
Cinchocaine—BCHE—central nervous system—epilepsy syndrome	0.000275	0.00621	CbGeAlD
Cinchocaine—BCHE—cerebellum—epilepsy syndrome	0.000269	0.00607	CbGeAlD
Cinchocaine—CALM2—brain—epilepsy syndrome	0.000262	0.00591	CbGeAlD
Cinchocaine—Oxybuprocaine—SCN2A—epilepsy syndrome	0.000261	0.0428	CrCbGaD
Cinchocaine—CALM1—brain—epilepsy syndrome	0.000261	0.00588	CbGeAlD
Cinchocaine—Amiodarone—CACNA1H—epilepsy syndrome	0.000258	0.0423	CrCbGaD
Cinchocaine—Procainamide—SCN8A—epilepsy syndrome	0.00025	0.0411	CrCbGaD
Cinchocaine—BCHE—brain—epilepsy syndrome	0.000218	0.00493	CbGeAlD
Cinchocaine—Procainamide—SCN9A—epilepsy syndrome	0.000202	0.0332	CrCbGaD
Cinchocaine—Procainamide—SCN3A—epilepsy syndrome	0.000194	0.0318	CrCbGaD
Cinchocaine—Procainamide—SCN4A—epilepsy syndrome	0.000186	0.0305	CrCbGaD
Cinchocaine—Procainamide—SCN1A—epilepsy syndrome	0.000136	0.0223	CrCbGaD
Cinchocaine—Metoclopramide—CHRM1—epilepsy syndrome	0.000133	0.0219	CrCbGaD
Cinchocaine—Oxybuprocaine—BCHE—epilepsy syndrome	0.000126	0.0206	CrCbGaD
Cinchocaine—Procainamide—SCN2A—epilepsy syndrome	0.00012	0.0197	CrCbGaD
Cinchocaine—Chloroprocaine—BCHE—epilepsy syndrome	0.000117	0.0192	CrCbGaD
Cinchocaine—Chloroquine—TNF—epilepsy syndrome	0.000108	0.0177	CrCbGaD
Cinchocaine—Procainamide—CHRM2—epilepsy syndrome	6.92e-05	0.0113	CrCbGaD
Cinchocaine—Amiodarone—CYP2C19—epilepsy syndrome	6.45e-05	0.0106	CrCbGaD
Cinchocaine—Chloroquine—CYP2D6—epilepsy syndrome	6.11e-05	0.01	CrCbGaD
Cinchocaine—Procainamide—BCHE—epilepsy syndrome	5.77e-05	0.00946	CrCbGaD
Cinchocaine—Metoclopramide—CYP2D6—epilepsy syndrome	4.98e-05	0.00818	CrCbGaD
Cinchocaine—Quinacrine—ABCB1—epilepsy syndrome	4.92e-05	0.00807	CrCbGaD
Cinchocaine—Amiodarone—CYP2D6—epilepsy syndrome	4.78e-05	0.00784	CrCbGaD
Cinchocaine—Chloroquine—ABCB1—epilepsy syndrome	4.37e-05	0.00716	CrCbGaD
Cinchocaine—Amiodarone—ABCB1—epilepsy syndrome	3.41e-05	0.0056	CrCbGaD
Cinchocaine—Procainamide—CYP2D6—epilepsy syndrome	3.17e-05	0.00519	CrCbGaD
Cinchocaine—CALM3—Signaling Pathways—JUNB—epilepsy syndrome	3.36e-06	2.62e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CNR1—epilepsy syndrome	3.36e-06	2.62e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—CCR5—epilepsy syndrome	3.35e-06	2.61e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—PLCB1—epilepsy syndrome	3.35e-06	2.61e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—HMOX1—epilepsy syndrome	3.33e-06	2.6e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—BDKRB2—epilepsy syndrome	3.31e-06	2.58e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CXCL12—epilepsy syndrome	3.31e-06	2.58e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CXCL12—epilepsy syndrome	3.31e-06	2.58e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—BDKRB2—epilepsy syndrome	3.31e-06	2.58e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by NGF—AKT1—epilepsy syndrome	3.31e-06	2.58e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by NGF—AKT1—epilepsy syndrome	3.31e-06	2.58e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—PRKCB—epilepsy syndrome	3.3e-06	2.57e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—PRKCB—epilepsy syndrome	3.3e-06	2.57e-05	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—VEGFA—epilepsy syndrome	3.29e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—VEGFA—epilepsy syndrome	3.29e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—CAT—epilepsy syndrome	3.29e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—IL6ST—epilepsy syndrome	3.28e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—IL6ST—epilepsy syndrome	3.28e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HTR7—epilepsy syndrome	3.28e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—TSC2—epilepsy syndrome	3.26e-06	2.54e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CRP—epilepsy syndrome	3.26e-06	2.54e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CRP—epilepsy syndrome	3.26e-06	2.54e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—TSC2—epilepsy syndrome	3.26e-06	2.54e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—JUNB—epilepsy syndrome	3.25e-06	2.53e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—JUNB—epilepsy syndrome	3.25e-06	2.53e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CNR1—epilepsy syndrome	3.25e-06	2.53e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CNR1—epilepsy syndrome	3.25e-06	2.53e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—CCR5—epilepsy syndrome	3.24e-06	2.53e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—CCR5—epilepsy syndrome	3.24e-06	2.53e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—PLCB1—epilepsy syndrome	3.24e-06	2.52e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—PLCB1—epilepsy syndrome	3.24e-06	2.52e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—HMOX1—epilepsy syndrome	3.22e-06	2.51e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—HMOX1—epilepsy syndrome	3.22e-06	2.51e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ABCB1—epilepsy syndrome	3.2e-06	2.49e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HBEGF—epilepsy syndrome	3.18e-06	2.48e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—CAT—epilepsy syndrome	3.18e-06	2.48e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—CAT—epilepsy syndrome	3.18e-06	2.48e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HTR7—epilepsy syndrome	3.17e-06	2.47e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HTR7—epilepsy syndrome	3.17e-06	2.47e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by Wnt—AKT1—epilepsy syndrome	3.15e-06	2.46e-05	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—SRC—epilepsy syndrome	3.14e-06	2.45e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—AKT3—epilepsy syndrome	3.12e-06	2.43e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—TSC2—epilepsy syndrome	3.11e-06	2.43e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—PRKCB—epilepsy syndrome	3.11e-06	2.43e-05	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—ALB—epilepsy syndrome	3.11e-06	2.42e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—POMC—epilepsy syndrome	3.1e-06	2.42e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL6ST—epilepsy syndrome	3.1e-06	2.42e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ABCB1—epilepsy syndrome	3.09e-06	2.41e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ABCB1—epilepsy syndrome	3.09e-06	2.41e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HBEGF—epilepsy syndrome	3.08e-06	2.4e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HBEGF—epilepsy syndrome	3.08e-06	2.4e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—ADAM10—epilepsy syndrome	3.05e-06	2.38e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by Wnt—AKT1—epilepsy syndrome	3.05e-06	2.38e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by Wnt—AKT1—epilepsy syndrome	3.05e-06	2.38e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—APOE—epilepsy syndrome	3.05e-06	2.38e-05	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—SRC—epilepsy syndrome	3.04e-06	2.37e-05	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—SRC—epilepsy syndrome	3.04e-06	2.37e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CCL2—epilepsy syndrome	3.04e-06	2.37e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—AKT3—epilepsy syndrome	3.02e-06	2.36e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—AKT3—epilepsy syndrome	3.02e-06	2.36e-05	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—SRC—epilepsy syndrome	3.02e-06	2.35e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—TSC2—epilepsy syndrome	3.01e-06	2.35e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—TSC2—epilepsy syndrome	3.01e-06	2.35e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—PRKCB—epilepsy syndrome	3.01e-06	2.35e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—PRKCB—epilepsy syndrome	3.01e-06	2.35e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—POMC—epilepsy syndrome	3e-06	2.34e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—POMC—epilepsy syndrome	3e-06	2.34e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL6ST—epilepsy syndrome	3e-06	2.34e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL6ST—epilepsy syndrome	3e-06	2.34e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—GPX1—epilepsy syndrome	2.97e-06	2.32e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—ADAM10—epilepsy syndrome	2.95e-06	2.3e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—ADAM10—epilepsy syndrome	2.95e-06	2.3e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—APOE—epilepsy syndrome	2.95e-06	2.3e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—APOE—epilepsy syndrome	2.95e-06	2.3e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CCL2—epilepsy syndrome	2.94e-06	2.29e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CCL2—epilepsy syndrome	2.94e-06	2.29e-05	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—SRC—epilepsy syndrome	2.92e-06	2.27e-05	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—SRC—epilepsy syndrome	2.92e-06	2.27e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—S100B—epilepsy syndrome	2.89e-06	2.25e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—GPX1—epilepsy syndrome	2.87e-06	2.24e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—GPX1—epilepsy syndrome	2.87e-06	2.24e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—IL6ST—epilepsy syndrome	2.86e-06	2.23e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SOCS3—epilepsy syndrome	2.86e-06	2.23e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CDC42—epilepsy syndrome	2.85e-06	2.22e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—FOS—epilepsy syndrome	2.84e-06	2.21e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—NOS2—epilepsy syndrome	2.84e-06	2.21e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—S100B—epilepsy syndrome	2.79e-06	2.18e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—S100B—epilepsy syndrome	2.79e-06	2.18e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CASP8—epilepsy syndrome	2.77e-06	2.16e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—IL6ST—epilepsy syndrome	2.77e-06	2.16e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—IL6ST—epilepsy syndrome	2.77e-06	2.16e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SOCS3—epilepsy syndrome	2.76e-06	2.15e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SOCS3—epilepsy syndrome	2.76e-06	2.15e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—AVP—epilepsy syndrome	2.76e-06	2.15e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CDC42—epilepsy syndrome	2.76e-06	2.15e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CDC42—epilepsy syndrome	2.76e-06	2.15e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—FOS—epilepsy syndrome	2.75e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—FOS—epilepsy syndrome	2.75e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—NOS2—epilepsy syndrome	2.75e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—NOS2—epilepsy syndrome	2.75e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—PTGS2—epilepsy syndrome	2.72e-06	2.12e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CASP8—epilepsy syndrome	2.68e-06	2.09e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CASP8—epilepsy syndrome	2.68e-06	2.09e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—AVP—epilepsy syndrome	2.67e-06	2.08e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—AVP—epilepsy syndrome	2.67e-06	2.08e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HES1—epilepsy syndrome	2.61e-06	2.03e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—AGT—epilepsy syndrome	2.61e-06	2.03e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—APOE—epilepsy syndrome	2.55e-06	1.99e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—FYN—epilepsy syndrome	2.54e-06	1.98e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—H2AFX—epilepsy syndrome	2.53e-06	1.97e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HES1—epilepsy syndrome	2.52e-06	1.97e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HES1—epilepsy syndrome	2.52e-06	1.97e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—MEF2C—epilepsy syndrome	2.52e-06	1.97e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—AGT—epilepsy syndrome	2.52e-06	1.96e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—AGT—epilepsy syndrome	2.52e-06	1.96e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—FGF2—epilepsy syndrome	2.51e-06	1.95e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—APOE—epilepsy syndrome	2.47e-06	1.92e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—APOE—epilepsy syndrome	2.47e-06	1.92e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—FYN—epilepsy syndrome	2.45e-06	1.91e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—FYN—epilepsy syndrome	2.45e-06	1.91e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—H2AFX—epilepsy syndrome	2.45e-06	1.91e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—H2AFX—epilepsy syndrome	2.45e-06	1.91e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—MEF2C—epilepsy syndrome	2.44e-06	1.9e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—MEF2C—epilepsy syndrome	2.44e-06	1.9e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—YWHAZ—epilepsy syndrome	2.44e-06	1.9e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—FGF2—epilepsy syndrome	2.43e-06	1.89e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—FGF2—epilepsy syndrome	2.43e-06	1.89e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—NGF—epilepsy syndrome	2.41e-06	1.88e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—BCL2—epilepsy syndrome	2.38e-06	1.86e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.36e-06	1.84e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.36e-06	1.84e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCR5—epilepsy syndrome	2.35e-06	1.83e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—NGF—epilepsy syndrome	2.33e-06	1.82e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—NGF—epilepsy syndrome	2.33e-06	1.82e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—RELA—epilepsy syndrome	2.33e-06	1.81e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—FGF2—epilepsy syndrome	2.32e-06	1.8e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—BCL2—epilepsy syndrome	2.3e-06	1.8e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—BCL2—epilepsy syndrome	2.3e-06	1.8e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HTR2A—epilepsy syndrome	2.3e-06	1.79e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—MTOR—epilepsy syndrome	2.28e-06	1.78e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCR5—epilepsy syndrome	2.27e-06	1.77e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCR5—epilepsy syndrome	2.27e-06	1.77e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—RELA—epilepsy syndrome	2.25e-06	1.76e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—RELA—epilepsy syndrome	2.25e-06	1.76e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—FGF2—epilepsy syndrome	2.24e-06	1.75e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—FGF2—epilepsy syndrome	2.24e-06	1.75e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HTR2A—epilepsy syndrome	2.22e-06	1.73e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HTR2A—epilepsy syndrome	2.22e-06	1.73e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—MTOR—epilepsy syndrome	2.21e-06	1.72e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—MTOR—epilepsy syndrome	2.21e-06	1.72e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—POMC—epilepsy syndrome	2.19e-06	1.71e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—TSC2—epilepsy syndrome	2.18e-06	1.7e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—AGT—epilepsy syndrome	2.18e-06	1.7e-05	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—AKT1—epilepsy syndrome	2.17e-06	1.69e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—APOE—epilepsy syndrome	2.13e-06	1.66e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—POMC—epilepsy syndrome	2.12e-06	1.65e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—POMC—epilepsy syndrome	2.12e-06	1.65e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—TSC2—epilepsy syndrome	2.11e-06	1.64e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—TSC2—epilepsy syndrome	2.11e-06	1.64e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—MTOR—epilepsy syndrome	2.11e-06	1.64e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—AGT—epilepsy syndrome	2.11e-06	1.64e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—AGT—epilepsy syndrome	2.11e-06	1.64e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL1B—epilepsy syndrome	2.1e-06	1.64e-05	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—AKT1—epilepsy syndrome	2.1e-06	1.63e-05	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—AKT1—epilepsy syndrome	2.1e-06	1.63e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—KDR—epilepsy syndrome	2.09e-06	1.63e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—PTGS2—epilepsy syndrome	2.09e-06	1.63e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—APOE—epilepsy syndrome	2.06e-06	1.61e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—APOE—epilepsy syndrome	2.06e-06	1.61e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—JUN—epilepsy syndrome	2.04e-06	1.59e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—MTOR—epilepsy syndrome	2.04e-06	1.59e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—MTOR—epilepsy syndrome	2.04e-06	1.59e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL1B—epilepsy syndrome	2.04e-06	1.59e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL1B—epilepsy syndrome	2.04e-06	1.59e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—KDR—epilepsy syndrome	2.02e-06	1.58e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—KDR—epilepsy syndrome	2.02e-06	1.58e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—PTGS2—epilepsy syndrome	2.02e-06	1.57e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—PTGS2—epilepsy syndrome	2.02e-06	1.57e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.01e-06	1.57e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IL6ST—epilepsy syndrome	2e-06	1.56e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ALB—epilepsy syndrome	2e-06	1.56e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—JUN—epilepsy syndrome	1.97e-06	1.54e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—JUN—epilepsy syndrome	1.97e-06	1.54e-05	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—AKT1—epilepsy syndrome	1.95e-06	1.52e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—PRKCB—epilepsy syndrome	1.95e-06	1.52e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.95e-06	1.52e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IL6ST—epilepsy syndrome	1.94e-06	1.51e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.94e-06	1.51e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ALB—epilepsy syndrome	1.93e-06	1.51e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ALB—epilepsy syndrome	1.93e-06	1.51e-05	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—AKT1—epilepsy syndrome	1.89e-06	1.47e-05	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—AKT1—epilepsy syndrome	1.89e-06	1.47e-05	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—AKT1—epilepsy syndrome	1.87e-06	1.46e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—POMC—epilepsy syndrome	1.83e-06	1.43e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—SRC—epilepsy syndrome	1.83e-06	1.43e-05	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—AKT1—epilepsy syndrome	1.81e-06	1.41e-05	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—AKT1—epilepsy syndrome	1.81e-06	1.41e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCL2—epilepsy syndrome	1.79e-06	1.4e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—POMC—epilepsy syndrome	1.77e-06	1.38e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—POMC—epilepsy syndrome	1.77e-06	1.38e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—SRC—epilepsy syndrome	1.77e-06	1.38e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—SRC—epilepsy syndrome	1.77e-06	1.38e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—PTGS2—epilepsy syndrome	1.75e-06	1.36e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCL2—epilepsy syndrome	1.74e-06	1.35e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCL2—epilepsy syndrome	1.74e-06	1.35e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—PTGS2—epilepsy syndrome	1.69e-06	1.32e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—PTGS2—epilepsy syndrome	1.69e-06	1.32e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—SRC—epilepsy syndrome	1.69e-06	1.32e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—SRC—epilepsy syndrome	1.63e-06	1.27e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—SRC—epilepsy syndrome	1.63e-06	1.27e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—FGF2—epilepsy syndrome	1.62e-06	1.26e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—FGF2—epilepsy syndrome	1.57e-06	1.22e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—FGF2—epilepsy syndrome	1.57e-06	1.22e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—RELA—epilepsy syndrome	1.51e-06	1.17e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—MTOR—epilepsy syndrome	1.48e-06	1.15e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—RELA—epilepsy syndrome	1.46e-06	1.13e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—RELA—epilepsy syndrome	1.46e-06	1.13e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—MTOR—epilepsy syndrome	1.43e-06	1.11e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—MTOR—epilepsy syndrome	1.43e-06	1.11e-05	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—AKT1—epilepsy syndrome	1.37e-06	1.06e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CASP3—epilepsy syndrome	1.36e-06	1.06e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—JUN—epilepsy syndrome	1.32e-06	1.03e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CASP3—epilepsy syndrome	1.31e-06	1.02e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CASP3—epilepsy syndrome	1.31e-06	1.02e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—MMP9—epilepsy syndrome	1.28e-06	1e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—JUN—epilepsy syndrome	1.28e-06	9.94e-06	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—JUN—epilepsy syndrome	1.28e-06	9.94e-06	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.24e-06	9.7e-06	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—MMP9—epilepsy syndrome	1.24e-06	9.67e-06	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—MMP9—epilepsy syndrome	1.24e-06	9.67e-06	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.2e-06	9.38e-06	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.2e-06	9.38e-06	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SRC—epilepsy syndrome	1.18e-06	9.22e-06	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.15e-06	8.98e-06	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SRC—epilepsy syndrome	1.14e-06	8.92e-06	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SRC—epilepsy syndrome	1.14e-06	8.92e-06	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—AKT1—epilepsy syndrome	1.14e-06	8.86e-06	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.11e-06	8.69e-06	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.11e-06	8.69e-06	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—AKT1—epilepsy syndrome	1.1e-06	8.57e-06	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—AKT1—epilepsy syndrome	1.1e-06	8.57e-06	CbGpPWpGaD
Cinchocaine—CALM3—Disease—AKT1—epilepsy syndrome	1.05e-06	8.18e-06	CbGpPWpGaD
Cinchocaine—CALM2—Disease—AKT1—epilepsy syndrome	1.02e-06	7.91e-06	CbGpPWpGaD
Cinchocaine—CALM1—Disease—AKT1—epilepsy syndrome	1.02e-06	7.91e-06	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—AKT1—epilepsy syndrome	8.79e-07	6.85e-06	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—AKT1—epilepsy syndrome	8.5e-07	6.63e-06	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—AKT1—epilepsy syndrome	8.5e-07	6.63e-06	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—AKT1—epilepsy syndrome	7.35e-07	5.73e-06	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—AKT1—epilepsy syndrome	7.11e-07	5.54e-06	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—AKT1—epilepsy syndrome	7.11e-07	5.54e-06	CbGpPWpGaD
